||5R01CA204819-03 Interpret this number
||Vanderbilt University Medical Center
||Breast Cancer in Blacks: Impact of Genomics, Healthcare Use and Lifestyle on Outcomes (BRIGHT)
Young Black women bear a disproportionate burden of breast cancer (BC) mortality compared to Whites
and are underrepresented in clinical studies. It remains critical to understand factors that contribute to the high
mortality from BC among young Black women in order to improve outcomes. The higher BC mortality rate
among young Blacks with BC is partly attributed to the disproportionately higher proportions who develop the
aggressive triple-negative (TN) BC subtype. In addition to biologic factors, timely access to care, and lifestyle
factors contribute to this disparity. Consequently, it has become imperative to look in detail within the Black
population to evaluate the interplay between biologic and non-biologic contributors to existing disparities, and
to better characterize the highly aggressive TNBC among young Black women based on distinct molecular
subtypes. Ultimately, it is critical to assess both biologic and non-biologic factors in order to fully understand
and address existing health disparities in young Black women. Through leveraging a prior population-based
study of 460 young Black women with invasive BC in 2009-2012 (and recruitment of a representative sample
of an additional 200 women diagnosed in 2013-2014), we plan to: 1) assess the contribution of biologic and
non-biologic factors on high mortality rates observed among young Black women with BC and generate a risk
score, to help identify those at risk for poorer outcomes, and 2) investigate molecular features of the subgroup
with TNBC. We hypothesize that biologic (including tumor gene expression profiling) and non-biologic factors
contribute to existing disparities in BC survival among young Black women. Furthermore, we hypothesize that
Blacks have a higher proportion of aggressive subtype of TNBC. To our knowledge, this is among the largest
population-based cohorts of young Black women with breast cancer. Ultimately, our study presents a unique
opportunity to quantify biological and non-biological factors associated with BC-specific survival, and further
characterize TNBC among Black women. Given that prior interventions have too narrowly focused on the
patient as the agent of change without meaningfully impacting the BC mortality disparity, it is important to
consider patient, provider and system level approaches concurrently to drive system change and close the
Strategies to enhance identification of hereditary breast cancer gene carriers.
, Spalluto L.B.
, Pal T.
Expert review of molecular diagnostics, 2020 Sep; 20(9), p. 861-865.
Disparities in BRCA counseling across providers in a diverse population of young breast cancer survivors.
, Cragun D.
, Tezak A.
, Weidner A.
, Moore J.
, Mayer I.A.
, Shu X.O.
, Ye F.
, Fan R.
, Vadaparampil S.
, et al.
Genetics in medicine : official journal of the American College of Medical Genetics, 2020 Jun; 22(6), p. 1088-1093.